Pfizer's Herceptin biosimilar approved in Europe

World |  News | 0 Comment | 31 Jul, 2018

Singapore – The European Commission approves Pfizer's TRAZIMERA, a biosimilar of Roche's cance...Read more

Thermo Fisher Scientific showcases latest solutions at HPLC 2018

World |  News | 0 Comment | 31 Jul, 2018

Supporting the innovation and application of high-performance liquid chromatography (HPLC) across novel and routine scie...Read more

Immunomedics announces multiple collaborations with cancer research institutions

World |  News | 0 Comment | 30 Jul, 2018

 Singapore- Immunomedics, a biopharmaceutical company in the area of antibody-drug conjugates (ADC), announced a co...Read more

Nektar's back pain opioid gets approval for FDA review

World |  News | 0 Comment | 30 Jul, 2018

 Singapore- The FDA accepts for review Nektar Therapeutics' marketing application seeking approval for NK...Read more

Scythian Biosciences signs LOI to acquire CannCure

World |  News | 0 Comment | 30 Jul, 2018

Singapore- Scythian Biosciences announced it has signed an arm’s length letter of intent effective July 26, 2018 t...Read more

GSK’s Nucala wins positive opinion from EMA for treatment of children with severe asthma

World |  News | 2 Comment | 30 Jul, 2018

GlaxoSmithKline has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Huma...Read more

3D printed scaffolds can regrow damaged nerves

World |  News | 0 Comment | 30 Jul, 2018

Scientists have developed tiny Three-dimensional (3D) -printed scaffolds that can guide the regrowth of nerve cells, pos...Read more

Chembio Diagnostics, FIND to develop HCV POC diagnostic test

World |  News | 0 Comment | 30 Jul, 2018

Chembio Diagnostics, Inc., a leader in point-of-care (POC) diagnostic testing, has announced a collaboration with the Fo...Read more

Siemens Healthineers launches heart attack diagnostic tests

World |  News | 0 Comment | 27 Jul, 2018

Siemens Healthineers has introduced two new assays for quick diagnosis of acute myocardial infarction or heart attack, f...Read more

Merck’s formulation steps further for approval in 21 EU countries

World |  News | 0 Comment | 26 Jul, 2018

Singapore- Merck, a leading science and technology company, announced that the German Federal Institute for Drugs and Me...Read more

XLerateHealth Accelerator selects ten companies for incoming sixth cohort

World |  News | 0 Comment | 26 Jul, 2018

XLerateHealth, an enterprise-focused healthcare accelerator that helps early-stage healthcare companies has announced it...Read more

GSK signs $300M genetic testing deal

World |  News | 0 Comment | 26 Jul, 2018

Singapore- GlaxoSmithKline has made a $300 million equity investment in the Silicon Valley gene testing compan...Read more

NanoSphere receives patent for nanoparticle delivery of Cannabis

World |  News | 0 Comment | 25 Jul, 2018

NanoSphere Health Sciences has been awarded a breakthrough patent, granting the biotech innovator full ownership over th...Read more

AstraZeneca sells European rights for heart failure treatment for $210M

World |  News | 0 Comment | 24 Jul, 2018

Singapore -  AstraZeneca has agreed to sell the European commercial rights to hypertension and heart...Read more

Biocept, UC collaborate on predicting disease recurrence in solid tumors

World |  News | 0 Comment | 24 Jul, 2018

Singapore -  Biocept, a leading commercial provider of liquid biopsy tests designed to provide physicians with clin...Read more

Tabula Rasa HealthCare’s SinfoníaRx releases RxCompanion 10.0 Software

World |  News | 0 Comment | 24 Jul, 2018

Tabula Rasa HealthCare, Inc., a healthcare technology company optimizing medication safety has announced a new generatio...Read more

FDA approves Tibsovo for AML patients

World |  News | 0 Comment | 23 Jul, 2018

Singapore – The U.S. Food and Drug Administration approved Tibsovo (ivosidenib) tablets for the treatment of adult...Read more

Agios receives nod for ivosidenib

World |  News | 0 Comment | 23 Jul, 2018

Singapore – The FDA approves Agios Pharmaceuticals' TIBSOVO (ivosidenib) for the treatment of adult pati...Read more